ITI (523610) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
29 Aug, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved by the Board on February 13, 2025.
The company continues to operate under a government-approved revival plan, with significant financial assistance received and ongoing support from the Government of India.
Financial highlights
Consolidated revenue from operations for the nine months ended December 31, 2024, was ₹1,03,454 lakhs, with total revenue at ₹1,05,470 lakhs; for the quarter, revenue was ₹25,884 lakhs.
Consolidated net loss for the nine months was ₹33,007 lakhs, and for the quarter, ₹4,888 lakhs, compared to a net loss of ₹56,906 lakhs for the year ended March 31, 2024.
Basic and diluted EPS for the nine months was (₹3.44), and for the quarter, (₹0.51).
Standalone results closely mirror consolidated figures, with similar revenue and loss patterns.
Outlook and guidance
Management asserts the going concern basis is appropriate, citing a high-value order book of ₹15,49,346 lakhs and expected conversion of unbilled revenue of ₹1,79,753 lakhs within 12 months.
Recovery processes are being stepped up to collect billed dues, and working capital borrowing is adequately sanctioned.
Latest events from ITI
- Ongoing losses, audit disclaimer, and reliance on government support amid operational risks.523610
Q3 202613 Feb 2026 - Q1 FY25 saw continued losses and auditor disclaimers, but management cites a robust order book.523610
Q1 24/2524 Nov 2025 - Q2 FY26 saw continued losses and auditor disclaimers amid unresolved financial uncertainties.523610
Q2 25/2613 Nov 2025 - Revenue up, losses persist, and auditors issue disclaimer amid major uncertainties.523610
Q2 24/2529 Aug 2025 - Significant revenue growth offset by persistent losses and major audit concerns in FY25.523610
Q4 24/2529 Aug 2025 - Q1 FY26 saw continued losses, high expenses, and auditor disclaimer amid compliance and receivable issues.523610
Q1 25/2629 Aug 2025